Effect of a Fibrate (Fenofibrate) and a Statin (Atorvastatin) and on Endothelial Dysfunction in Diabetes Mellitus and the Metabolic Syndrome.
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2012
At a glance
- Drugs Atorvastatin (Primary) ; Fenofibrate (Primary)
- Indications Metabolic syndrome; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 Mar 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 23 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2007 New trial record.